TO THE EDITOR
Two main morphological acute promyelocytic leukemia (APL) variants are recognized. In the classical hypergranular form, the predominant leukemic cells are abnormal hypergranular promyelocytes with cells containing bundles of Auer rods. The variant hypogranular-microgranular form is characterized by the proliferation of blast cells with bilobed or reniform nuclei, and a cytoplasm which is either agranular or has very fine granules; a few cells with typical features of the classical form are, however, present in the bone marrow. A very rare hyperbasophilic form has been reported by McKenna et al, 1 in which promyelocytes are small with a strong basophilic cytoplasm and prominent budding resembling micromegakaryocytes. The cytogenetic hallmark of APL is the translocation t(15;17)(q22;q21), which results in the fusion of the PML gene on chromosome 15 and the RAR␣ gene on chromosome 17 producing a PML/RAR␣ chimeric gene. We describe an unusual case of acute leukemia with atypical clinical, morphologic and immunophenotypic features of APL.
A 22-year-old female was admitted to our hospital in September 1996 with fever and easy bruising. Peripheral blood counts showed hemoglobin of 98 g/l, 19 × 10 9 /l platelets and 8.8 × 10 9 /l leukocytes with 87% blast cells. All coagulation parameters were normal. Bone marrow (BM) aspirate yielded little material and cellularity was composed of 90% medium and large blast cells with basophilic cytoplasm devoid of granules; most of the leukemic cells showed a convoluted nuclei and cytoplasmic protusions ( Figure 1 ). No hypergranular promyelocytes were detected. Cytochemical staining revealed positivity for myeloperoxidase and negativity for alpha-naphthyl acetate esterase. BM biopsy showed a cellular infiltrate of undifferentiated cells. An increase in reticulin was also observed. The immunophenotype of peripheral blast cells was: CD2 33%, CD4 28% (weak), CD13 79%, CD33 83%, CD34 90%, CD36 41%, CD56 34% (weak), HLA-DR 60%, cMPO 22%, CD117 86%, and CD3, cCD3, CD5, CD7, CD10, CD11b, CD14, CD19, CD20,cCD22, CD41, CD61, glycophorin A, negative. Cytogenetic study showed a 46, XX, t(15;17)(q22;q21) karyotype (Figure 2 ). Figure 3 shows the results of RT-PCR amplification of PML/RAR␣ mRNA from the patient's bone marrow. A fragment of 324 bp was amplified (lane 1) corresponding to the bcr3-type transcript. A diagnosis of APL was made. Complete hematologic remission was obtained after 5 weeks of therapy with all-trans retinoic acid (ATRA). Successive cycles of induction, consolidation and intensification chemotherapy were given. RT-PCR became negative after intensification chemotherapy and remained negative at last follow-up in September 1997.
Hematological diagnosis of acute leukemias is mainly based on morpho-cytochemical proposals of the cooperative FAB group. Morphologically, most of the leukemic cells in our case 
Figure 1
Bone marrow smear showing blast cells with convoluted nuclei and cytoplasmic blebs resembling megakaryoblasts (MayGrü nwald Giemsa × 1000).
resembled those described in the hyperbasophilic form of APL reported by McKenna et al, 1 but unlike our patient, McKenna's cases were described in the context of a typical microgranular variant APL-M3-FAB in which hypergranular promyelocytes with Auer rods and/or faggot cells, although uncommon, were present. It could be argued that we did not obtain sufficient bone marrow material due to the fibrosis. However, bone marrow trephine was fully replaced by leukoblasts without evidence of granulopoietic differentiation or hypergranular promyelocytes containing Auer rods. Nevertheless, Neame et al 2 recently reported seven out of 25 cases with APL, all of which were regarded as hyperbasophilic microgranular variants, 1 even in the absence of cells with Auer rods or with as few as 1% of hypergranular cells. Furthermore, they describe two additional microgranular variants resembling FAB M1 and FAB M2 subtypes. According to FAB criteria our patient would not have been classified as a traditional M3. Indeed, the fact that bone marrow was difficult to aspirate together with the megakaryoblast-like appearance of leukemic cells could, at first sight, suggest a true megakaryoblastic leukemia with fibrosis. Reticulin fibrosis has been reported as an unusual feature in a case of APL. 3 Immunophenotyping of the blast cells showed an immature myeloid phenotype characterized by positivity of CD13, CD33, CD117, cMPO, CD34, CD34, HLA-DR. Several studies on immunophenotype of APL have identified a characteristic antigenic profile: DR
, making monoclonal antibody studies essential in the diagnosis of APL. However, as our patient illustrates, the use of standard morphology and immunophenotyping as first-line diagnosis would fail to detect such cryptic APL. In the literature survey we found four additional cases with a FAB morphology different from M3-FAB, which have been reported to be associated with typical t(15;17) and/or PML/RAR␣ chimeric gene, including a patient with an acute eosinophilic granulocytic leukemia. [4] [5] [6] [7] The last patient achieved complete remission after differentiation treatment with ATRA, as our patient. As has been observed, 2 this reinforces the importance of the PML/RAR␣ fusion gene in the clinical outcome of APL patients. 
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